SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 138 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 1.23 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $1,526,000 | -40.3% | 142,737 | -51.1% | 0.22% | -46.7% |
| Q4 2018 | $2,556,000 | -71.7% | 292,129 | -45.7% | 0.42% | -61.7% |
| Q3 2018 | $9,032,000 | +1.2% | 537,644 | +26.3% | 1.09% | -7.4% |
| Q2 2018 | $8,923,000 | +4.9% | 425,702 | -19.5% | 1.18% | -8.0% |
| Q1 2018 | $8,507,000 | +23.8% | 528,715 | +45.8% | 1.28% | +19.5% |
| Q4 2017 | $6,872,000 | -6.2% | 362,615 | -70.4% | 1.07% | -37.7% |
| Q3 2015 | $7,324,000 | -57.2% | 1,224,692 | -51.0% | 1.72% | -8.1% |
| Q2 2015 | $17,098,000 | +123.4% | 2,499,638 | +98.2% | 1.87% | +19.8% |
| Q1 2015 | $7,655,000 | -4.6% | 1,261,162 | +8.9% | 1.56% | -2.3% |
| Q4 2014 | $8,025,000 | -0.8% | 1,158,070 | +16.5% | 1.60% | -8.1% |
| Q3 2014 | $8,092,000 | +29.2% | 994,120 | +29.0% | 1.74% | +38.3% |
| Q2 2014 | $6,264,000 | +45.9% | 770,520 | +40.8% | 1.26% | +51.3% |
| Q1 2014 | $4,292,000 | – | 547,404 | – | 0.83% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 787,973 | $615,000 | 0.77% |
| CM Management, LLC | 600,000 | $468,000 | 0.50% |
| ARMISTICE CAPITAL, LLC | 17,100,000 | $13,338,000 | 0.23% |
| Sargent Investment Group, LLC | 614,600 | $479,000 | 0.15% |
| Ergoteles LLC | 744,275 | $581,000 | 0.02% |
| Sonora Investment Management Group, LLC | 103,000 | $80,000 | 0.01% |
| CAXTON ASSOCIATES LP | 107,135 | $84,000 | 0.01% |
| MCDONALD PARTNERS LLC | 42,570 | $33,000 | 0.01% |
| Pinz Capital Management, LP | 15,600 | $12,000 | 0.01% |
| D. E. Shaw & Co., Inc. | 8,051,858 | $6,281,000 | 0.01% |